Amanote Research

Amanote Research

    RegisterSign In

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-12-0585
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

February 1, 2013

Authors
Britta WeigeltJorge S. Reis-Filho
Publisher

American Association for Cancer Research (AACR)


Related search

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

An Ad5[E1-, E2b-]-Her2/Neu Vector Induces Immune Responses and Inhibits HER2/neu Expressing Tumor Progression in Ad5 Immune Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2011English

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Simultaneous Detection of Expression and Gene Mutations of HER2/neu in Chinese Patients With Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2010English

MEK; HER2 (EGFR2; ERBB2; Neu); PTEN (MMAC1; TEP1)

Science-Business eXchange
2011English

HER2/neu: An Increasingly Important Therapeutic Target. Part 2: Distribution of HER2/neu Overexpression and Gene Amplification by Organ, Tumor Site and Histology

Clinical Investigation
2014English

ErbB-2/Her2/neu Overexpression and Estrogen-Dependency in Breast Carcinogenesis

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy